SystemOne Transfers Full Ownership of National TB Diagnostic Platform to Bangladesh Government
- 45 minutes ago
- 4 min read
Released on World TB Day 2026: A first-of-its-kind technology sovereignty model delivers source code transfer, embedded local engineers, and a validated handover to national control, demonstrating that diagnostic connectivity can outlast donor funding and deliver lasting country self-reliance.
NORTHAMPTON, MA, March 24, 2026. SystemOne, LLC, a global health technology company specializing in diagnostic connectivity and disease surveillance, today announced a fully executed services agreement with Bangladesh's Directorate General of Health Services (DGHS), National TB Program (NTP), and Management Information System (MIS). The agreement marks a significant departure from conventional global health software procurement, establishing a model of permanent national ownership, in-country capacity, and full technology transfer.
The announcement is released on World TB Day to underscore what the global TB community is increasingly demanding: health infrastructure that countries own, operate, and sustain, independent of any single funding cycle.
Under the agreement, SystemOne will transfer complete ownership of the Aspect™ platform, which currently connects more than 700 GeneXpert instruments and will expand to 150 TrueNAT devices across Bangladesh, to the Bangladesh government by the end of 2026. The transfer includes source code, local server infrastructure, and full developer training, with Bangladesh-based engineers embedded within the SystemOne team throughout the contract period, ensuring genuine skills transfer rather than perpetual dependency.
“This is what global health done right looks like. We are not selling Bangladesh a subscription; we are handing them the keys. When this contract ends, they own their platform, the code, the infrastructure, and the expertise to run it independently. That is what self-reliance actually means.”
-- Nicolas Boillot, CEO, SystemOne
STRENGTHENING THE GLOBAL TB RESPONSE THROUGH DATA SOVEREIGNTY
Bangladesh carries one of the world's highest tuberculosis burdens, with diagnostic capacity central to the country's End TB targets. Connecting instruments to a national data platform is not merely a technical achievement; it enables real-time case detection, program monitoring, treatment cascade analysis, and outbreak response. Critically, this agreement ensures that capacity persists beyond any single funding cycle.
Key features of direct relevance to global TB program and U.S. global health priorities:
Country ownership and self-reliance: Full source code, server infrastructure, and operational control transfer permanently to the Bangladesh government, eliminating perpetual vendor dependency, a goal explicitly called for in the U.S. America First Global Health Strategy and by the Stop TB Partnership alike.
End TB Strategy alignment: Real-time connectivity across 700+ GeneXpert and 150 TrueNAT devices directly supports universal drug-susceptibility testing and rapid case notification, two pillars of the WHO End TB Strategy.
Measurable, accountable investment: Every deliverable, connected instruments, local developers, server migration, and security assessment, carries defined timelines and accountability milestones, consistent with U.S. government priorities for targeted, results-driven global health spending.
Local capacity and economic investment: Full-time Bangladesh-based software engineers will be hired, trained, and integrated into the SystemOne engineering team, building durable technical human capital in-country and reducing reliance on external contractors.
Disease surveillance and pandemic preparedness: Continuous, real-time diagnostic data from a connected national TB network is foundational infrastructure for early outbreak detection, directly supporting the U.S. goal of containing health threats before they spread globally.
Scalability to other pathogens: The same connectivity architecture can extend to HIV, COVID-19, antimicrobial resistance, and other infectious disease priorities, multiplying the return on a single infrastructure investment.
Transition from surge to resilience: A structured Transition Readiness Review in August 2026 and a Final Handover milestone in July to September 2026 ensure a planned, validated exit rather than an abrupt withdrawal.
A REPLICABLE MODEL FOR SUSTAINABLE DIAGNOSTIC CONNECTIVITY
The conventional approach to global health technology, subscription platforms dependent on recurring donor disbursements, creates structural fragility. When funding is cut, reduced, or redirected, national programs lose access to systems they depend on but do not own. SystemOne structured the Bangladesh engagement differently: as a one-time technology and capacity transfer rather than a recurring service contract, analogous to building a road rather than renting one.
The Scope of Work covers nine integrated workstreams running through 2026:
Recruitment and integration of Bangladesh-based software engineers
Ongoing GeneXpert connectivity support for approximately 705 instruments
TrueNAT connectivity and Android application development for 150 Molbio TrueLab devices
Local server hosting migration to government-controlled infrastructure
Developer training and DevOps enablement
SIM card transition to national management and ownership
Government-mandated Vulnerability Assessment and Penetration Testing (VAPT) security review
Formal Transition Readiness Review (August 2026)
Final handover and validation (July to September 2026)
At contract close, Bangladesh will hold complete source code repositories, deployment documentation, database infrastructure, and the in-country technical human capital to operate and evolve the system without external support.
“What we’ve built in Bangladesh is a proof of concept that global health technology can be both sustainable and aligned with values that transcend any single donor,” said Boillot. “Accountability, measurable results, national sovereignty, efficiency: these are not in conflict with effective global health. They should define it.”
SystemOne is prepared to discuss how this model can be adapted for other high-burden countries where global health partners are seeking to build lasting diagnostic infrastructure beyond the current funding cycle.
ABOUT SYSTEMONE
SystemOne, LLC is a health technology company headquartered in Northampton, Massachusetts, dedicated to connecting diagnostic instruments and improving health outcomes through real-time data. SystemOne's Aspect™ and GxAlert® platforms have been deployed in more than 40 countries, supporting tuberculosis, HIV, and other infectious disease programs by delivering diagnostic connectivity, automated reporting, and data-driven decision support to ministries of health, national disease programs, and global health partners.
MEDIA CONTACT
Brad Cunningham, COO
SystemOne, LLC
296 Nonotuck Street, Northampton, MA 01062
###